Previous Close | 11.99 |
Open | 11.76 |
Bid | 11.56 x 1200 |
Ask | 11.78 x 2200 |
Day's Range | 11.48 - 12.09 |
52 Week Range | 3.85 - 14.20 |
Volume | |
Avg. Volume | 4,628,531 |
Market Cap | 2.664B |
Beta (5Y Monthly) | 1.59 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.83 |
Earnings Date | Feb 13, 2023 - Feb 17, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.14 |
Subscribe to Yahoo Finance Plus to view Fair Value for PACB
Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...
Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock at a price to the public of $10.00 per share. PacBio has granted the underwriters a 30-day option to purchase up to an additional 2,625,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares are to be sold by PacBio. Before deducting t
Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock, at the public offering price, less underwriting discounts and commissions. The proposed offering is subject to market and other conditions and there can be no assur